Clone Phylogenetics Reveals Metastatic Tumor Migrations, Maps, and Models

被引:5
|
作者
Chroni, Antonia [1 ,2 ]
Miura, Sayaka [1 ,2 ]
Hamilton, Lauren [1 ,2 ]
Vu, Tracy [1 ,2 ]
Gaffney, Stephen G. [3 ]
Aly, Vivian [1 ,2 ]
Karim, Sajjad [4 ]
Sanderford, Maxwell [1 ,2 ]
Townsend, Jeffrey P. [3 ,5 ,6 ]
Kumar, Sudhir [1 ,2 ,4 ]
机构
[1] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] Yale Univ, Dept Biostat, New Haven, CT 06510 USA
[4] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 22252, Saudi Arabia
[5] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06525 USA
[6] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA
基金
美国国家卫生研究院;
关键词
tumor evolution; metastasis; molecular evolution; phylogenetics; phylodynamics; cancer; HETEROGENEITY;
D O I
10.3390/cancers14174326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Metastasis is the spread of cancer cells across organs and is a major cause of cancer mortality. Analysis of tumor sequencing data provides a means toward the reconstruction of routes of metastatic cell migrations. Our reconstructions demonstrated that many metastases were likely seeded from pre-existing metastasis of primary tumors. Additionally, multiple clone exchanges between tumor sites were common. In conclusion, the pattern of cancer cell migrations is often complex and is highly variable among patients. Dispersal routes of metastatic cells are not medically detected or even visible. A molecular evolutionary analysis of tumor variation provides a way to retrospectively infer metastatic migration histories and answer questions such as whether the majority of metastases are seeded from clones within primary tumors or seeded from clones within pre-existing metastases, as well as whether the evolution of metastases is generally consistent with any proposed models. We seek answers to these fundamental questions through a systematic patient-centric retrospective analysis that maps the dynamic evolutionary history of tumor cell migrations in many cancers. We analyzed tumor genetic heterogeneity in 51 cancer patients and found that most metastatic migration histories were best described by a hybrid of models of metastatic tumor evolution. Synthesizing across metastatic migration histories, we found new tumor seedings arising from clones of pre-existing metastases as often as they arose from clones from primary tumors. There were also many clone exchanges between the source and recipient tumors. Therefore, a molecular phylogenetic analysis of tumor variation provides a retrospective glimpse into general patterns of metastatic migration histories in cancer patients.
引用
收藏
页数:13
相关论文
共 48 条
  • [41] Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis
    Amin, Asif
    Koul, Aabid Mustafa
    Wani, Umer Majeed
    Farooq, Faizah
    Amin, Basit
    Wani, Zubair
    Lone, Asif
    Qadri, Ayub
    Qadri, Raies A.
    BMC CANCER, 2023, 23 (01)
  • [42] Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis
    Asif Amin
    Aabid Mustafa Koul
    Umer Majeed Wani
    Faizah Farooq
    Basit Amin
    Zubair Wani
    Asif Lone
    Ayub Qadri
    Raies A. Qadri
    BMC Cancer, 23 (1)
  • [43] Untargeted 2D NMR Metabolomics of [13C-methyl]Methionine-Labeled Tumor Models Reveals the Non-DNA Methylome and Provides Clues to Methyl Metabolism Shift during Tumor Progression
    Morvan, Daniel
    Cachin, Florent
    JOURNAL OF PROTEOME RESEARCH, 2022, 21 (04) : 940 - 952
  • [44] Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab
    Pickl, M.
    Ries, C. H.
    ONCOGENE, 2009, 28 (03) : 461 - 468
  • [45] Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity
    Patel, Apurva R.
    Godugu, Chandraiah
    Wilson, Heather
    Safe, Stephen
    Singh, Mandip
    PHARMACEUTICAL RESEARCH, 2015, 32 (07) : 2292 - 2300
  • [46] p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
    Emily Powell
    Jiansu Shao
    Yuan Yuan
    Hsiang-Chun Chen
    Shirong Cai
    Gloria V. Echeverria
    Nipun Mistry
    Keith F. Decker
    Christopher Schlosberg
    Kim-Anh Do
    John R. Edwards
    Han Liang
    David Piwnica-Worms
    Helen Piwnica-Worms
    Breast Cancer Research, 18
  • [47] p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
    Powell, Emily
    Shao, Jiansu
    Yuan, Yuan
    Chen, Hsiang-Chun
    Cai, Shirong
    Echeverria, Gloria V.
    Mistry, Nipun
    Decker, Keith F.
    Schlosberg, Christopher
    Do, Kim-Anh
    Edwards, John R.
    Liang, Han
    Piwnica-Worms, David
    Piwnica-Worms, Helen
    BREAST CANCER RESEARCH, 2016, 18
  • [48] Genomic models of metastatic cancer - Functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated polycomb group (PcG) protein chromatin silencing pathway
    Glinsky, GV
    CELL CYCLE, 2006, 5 (11) : 1208 - 1216